cosibelimab
fortress,tg therapeutics,Checkpoint Therapeutics 
['cosibelimab', 'pivotal']
checkpoint therapeutics announces presentation of pivotal trial results of cosibelimab at the 2022 american society of clinical oncology (asco) annual meeting 
We provide a balanced view on small cap biotech equities.